# Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan – FDA Inspections

Source: https://www.keypedia.com/companies/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/d07820ec-a994-41cb-b667-509183a6cc4a

> Inspection records and compliance data for Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. in Tokushima. 7 FDA inspections on record, 2 Form 483s, last inspected March 22, 2024.

---

## Details

- Name: Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
- FEI Number: 3002807834
- Address Line 1: 224-18, Kawauchi-Cho
- City: Tokushima
- Country Name: Japan
- Address: 224-18, Kawauchi-Cho, Tokushima, Japan
- Country: Japan

## Related Documents

- [483 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2025-07-11](https://www.keypedia.com/records/483/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/361ad21c-4440-49cb-aca1-dd4e7dcc8cbf) — source: FDA, date: July 11, 2025
- [483 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2024-03-22](https://www.keypedia.com/records/483/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/ae73bd67-e93b-48af-8279-d731014ad321) — source: FDA, date: March 22, 2024
- [FDA Inspection 1230640 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2024-03-22](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/ea9811aa-4107-436d-8e97-c772f1bed4ec) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 22, 2024
- [483 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2019-09-10](https://www.keypedia.com/records/483/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/a01cb126-0c4a-4d16-a221-71b853e8bff1) — source: FDA, date: September 10, 2019
- [FDA Inspection 1106423 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2019-09-10](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/fffa5f62-5ff7-461b-9118-e485bdad04e8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 10, 2019
- [FDA Inspection 1049653 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2018-03-23](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/1ea9dae0-e4fd-4cb3-a59d-f9b811fe8d21) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 23, 2018
- FDA Inspection 958528 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2016-02-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 12, 2016
- FDA Inspection 958528 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2016-02-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 12, 2016
- FDA Inspection 888415 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2014-06-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 26, 2014
- FDA Inspection 801261 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2012-07-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 9, 2012
- FDA Inspection 754802 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2011-10-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 27, 2011

## Related Companies

- [Chugai Pharma Manufacturing Co. Ltd.](https://www.keypedia.com/companies/chugai-pharma-manufacturing-co-ltd/09ba6515-9227-444c-a24c-a6cb8da9e235)
- [Abbvie Biotechnology Ltd.](https://www.keypedia.com/companies/abbvie-biotechnology-ltd/b438b15a-033c-469a-8973-66b6506bba41)
- [Boehringer Ingelheim Biopharmaceuticals (China) Ltd.](https://www.keypedia.com/companies/boehringer-ingelheim-biopharmaceuticals-china-ltd/be450a8b-4f71-4f06-96b3-908a2ed1b580)
- [Regeneron Pharmaceuticals Inc](https://www.keypedia.com/companies/regeneron-pharmaceuticals-inc/cd765cfa-95e6-4023-ade2-0ffa382fe2c7)
- [Sun Pharmaceutical Medicare Limited](https://www.keypedia.com/companies/sun-pharmaceutical-medicare-limited/bcde6f4d-9644-445c-b813-cb49ed881f97)
- [Wacker Biotech B.V.](https://www.keypedia.com/companies/wacker-biotech-bv/9bd47c05-6585-4710-a9ea-4bd04e15dd4f)
- [Janssen Biotech, Inc.](https://www.keypedia.com/companies/janssen-biotech-inc/5374365d-a0df-4a87-ad3d-2714628d3e57)
- [BSP Pharmaceuticals SpA](https://www.keypedia.com/companies/bsp-pharmaceuticals-spa/cbf52ec3-50e2-4cf1-9f81-f0f7a74473fc)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/a659fe71-9183-4c7c-96ca-9214c6a9c177)
- [Eriochem SA](https://www.keypedia.com/companies/eriochem-sa/e2f01909-c1a5-49e0-a736-041a0c65beba)

## Related Officers

- [investigator](https://www.keypedia.com/people/michael-y-philopoulos/3ac66ef5-f279-408d-bc21-028421ed1104)
- [Investigator](https://www.keypedia.com/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)
- [investigator](https://www.keypedia.com/people/marian-e-ramirez/4b718b67-fee0-488c-9354-ee366d3510ad)
- [Plant Manager](https://www.keypedia.com/people/ryosuke-hirota/facecd94-becf-4065-b4f3-77cf24764dc1)
